Navigation Links
Director of Berman Institute comments on FDA Approval of first human embryonic stem cell trial
Date:1/23/2009

"The report today that the FDA has approved the first human clinical trial of an embryonic stem cell-based intervention raises important ethical considerations, but not only, or even primarily, because what is at issue is an embryonic stem cell-based intervention. Although deep-seated disagreements about the ethics of embryo research surround the interest in this study, we need to focus as well on this being the first human trial of its kind. Any "first in human beings" medical experiment requires the highest level of moral scrutiny and oversight. At this point it is critical that every effort be made to protect the welfare and rights of the patients who will be approached to be these human subjects. A good place to start would be by NOT referring to this study as a trial of a stem cell-based therapy, as Geron has described it, but rather as a stem cell-based intervention whose therapeutic benefits in humans has not yet been studied. It is also important to emphasize that this trial offers little prospect of clinical improvement to the very first patients who will participate in the safety phase of the research."


'/>"/>

Contact: Ralph Loglisci
RalphL@jhu.edu
410-625-7872
Johns Hopkins Berman Institute of Bioethics
Source:Eurekalert

Page: 1

Related biology news :

1. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
2. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
3. Director of National Intelligence to Speak at Conference
4. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
5. Director of National Intelligence to Speak at Conference
6. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
7. Ingram Micro to Distribute New Fujitsu Biometric Login Products for Novell eDirectory in United States
8. Solidus Networks, Inc. Seats New Board of Directors
9. Fujitsu Announces PalmSecure(TM) LOGONDIRECTOR
10. Julia Zeitlinger selected for NIH Directors New Innovator Award
11. bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
(Date:3/22/2017)... Calif. , March 22, 2017  UBM ... proud to announce their extended partnership and the ... be headlined by the 21 st Annual ... Boston, taking place May 3-4, 2017. ... Medical Technology Association (ADVAMED) President and CEO, ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com News ... ... conditions are being pressured as of late due to the ... pain management has a dramatic impact on patient,s quality of ... development activities for identifying new forms of opioid formulations that ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced ... of their live events series, “Stem Cell Therapy: The Next Phase in the Evolution ... 2013 Stem Cell Research and Therapy Act, Okyanos maintains a mission to ...
Breaking Biology Technology: